Effect Sizes and Primary Outcomes in Large-Budget, Cardiovascular-Related Behavioral Randomized Controlled Trials Funded by NIH Since 1980-Reference-Cited by-同舟云学术

Effect Sizes and Primary Outcomes in Large-Budget, Cardiovascular-Related Behavioral Randomized Controlled Trials Funded by NIH Since 1980

Published:2015-10-27 Issue:1 Volume:50 Page:130-146
ISSN:0883-6612
Container-title:Annals of Behavioral Medicine
language:en
Short-container-title:ann. behav. med.

Author:

Irvin Veronica L.,Kaplan Robert M.

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health,General Psychology

Link

http://link.springer.com/content/pdf/10.1007/s12160-015-9739-7.pdf

Reference73 articles.

1. Fisher EB, Fitzgibbon ML, Glasgow RE, et al. Behavior matters. Am J Prev Med. 2011; 40: e15-30.

2. Neiberg RH, Wing RR, Bray GA, et al. Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study. Obesity (Silver Spring). 2012; 20: 2048-2056.

3. Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369: 145-154.

4. World Health Organization. Non-communicable diseases. Available at http://www.who.int/mediacentre/factsheets/fs355/en/ . Accessibility verified July 3, 2015.

5. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25 Suppl 2): S49-73.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it Time to Abandon the Use of P-Values in Early Phase Translational Trials: Why (Effect) Size Matters;JACC: Basic to Translational Science;2024-02

2. Individual differences in the effects of the ACTION-PAC intervention: an application of personalized medicine in the prevention and treatment of obesity;Journal of Behavioral Medicine;2022-01-15

3. Preferences, Equipoise, and Blinding;Behavioral Clinical Trials for Chronic Diseases;2021

4. 2018 International Behavioural Trials Network (IBTN) Conference Abstracts;Annals of Behavioral Medicine;2019-02-14

5. 2018 International Behavioural Trials Network (IBTN) Conference Abstracts;Annals of Behavioral Medicine;2019-02-14